Winkler, Thomas W. http://orcid.org/0000-0003-0292-5421
Grassmann, Felix
Brandl, Caroline
Kiel, Christina
Günther, Felix
Strunz, Tobias
Weidner, Lorraine
Zimmermann, Martina E.
Korb, Christina A.
Poplawski, Alicia
Schuster, Alexander K.
Müller-Nurasyid, Martina
Peters, Annette
Rauscher, Franziska G.
Elze, Tobias
Horn, Katrin
Scholz, Markus
Cañadas-Garre, Marisa
McKnight, Amy Jayne
Quinn, Nicola
Hogg, Ruth E.
Küchenhoff, Helmut
Heid, Iris M.
Stark, Klaus J.
Weber, Bernhard H. F.
Funding for this research was provided by:
National Institutes of Health (HHSN268201200008I, R01 EY RES 511967, R01 EY022310)
Deutsche Forschungsgemeinschaft (HE 3690/5-1, HE-3690/5-1, GR 5065/1-1, GR 5065/1-1)
Bundesministerium für Bildung und Forschung (01ER1206, 01ER1507, 031L0026)
Free State of Saxony (713-241202, 14505/2470, 14575/2470)
National Eye Institute (R21EY030142, R21EY030631, R01EY030575, P30EYE003790)
Rhineland-Palatinate (AZ 961-386261/733)
Deutsche Akademie der Naturforscher Leopoldina - Nationale Akademie der Wissenschaften (LPDS 2018-06)
Helmut-Ecker-Foundation (05/17)
Article History
Received: 16 October 2019
Accepted: 4 August 2020
First Online: 26 August 2020
Ethics approval and consent to participate
: The Institutional Review Board (IRB) of the University of Utah was the umbrella IRB for all other studies contributing data to the International Age-related Macular Degeneration Genomics Consortium (IAMDGC), except for the Beaver Dam Eye Study (BDES). The University of Utah approved and certified each individual study ethic committee’s conduct for the data used in this study. Data provided by BDES was approved by the IRB of the University of Wisconsin. Local ethics approval for data access to the studies deposited in dbGAP (WHI, ARIC and CHS) was granted by the IRB of the University of Regensburg. For all other studies, study participants obtained informed consent and local ethics committees approved the study protocols.
: Not applicable.
: M.S. receives funding from Pfizer Inc. for a project not related to this research. Retinal grading of the NICOLA study was supported by Novartis (for R.E.H) and Bayer (for Usha Chakravarthy, not a co-author). A.K.S. received financial and research support by Heidelberg Engineering, Novartis, Bayer Vital and Allergen without a link to the content of this work. I.M.H. received funding from Roche Diagnostics for a project not related to this research. None of the other authors have any conflicts of interest.